US Patent Issued to EMORY UNIVERSITY, KODIKAZ THERAPEUTIC SOLUTIONS on Oct. 28 for "Nucleic acids for cell recognition and integration" (Georgia, California Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,740, issued on Oct. 28, was assigned to EMORY UNIVERSITY (Atlanta) and KODIKAZ THERAPEUTIC SOLUTIONS INC. (New York).

"Nucleic acids for cell recognition and integration" was invented by Leon Bernal-Mizrachi (Atlanta) and Matthew Charles Tindall (Piedmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides nucleic acid sequences and nucleic acid delivery constructs comprising "zip code" sequence(s) that home, target, cross a cytoplasm, and/or cross a nuclear membrane of a target cell (e.g., a diseased cell such as a cancer cell) or cell population (e.g., tissue), and integration sequence(s) that allow for integrati...